From: A survey in Mexico about ethics dumping in clinical research
Broad categories | Replies |
---|---|
Patients (15 mentions) | Conditions, rights, safety, follow-up, autonomy, actual volunteering, compensation, selection, management, care, vulnerability, adverse events. |
Committees (12 mentions). | Reexamining ongoing research, member profile, requirements, policies, auditing, member training and education, CONBIOÉTICA monitoring, numbers, researchers, certification, protocol revision times. |
Consent (8 mentions). | Informed consent letters |
Regulations (7 mentions). | Knowledge, regulation processes, best practices, applications, ethics. |
Industry (5 mentions). | Dependence, bioethics and bioethics education for management, coercion, corruption, agreements, conflicts of interest. |
Researchers (5 mentions). | Experience, ethics, planning and selection, ethic education, thought leaders. |
Protocols (4 mentions). | Truthfulness, exclusion criteria, diagnostic criteria, treatment design, patient selection, patient follow-up. |
Sites (4 mentions). | Certifications, requirements, screening by authorities, proceedings and operation. |
Declaration of Helsinki (4 mentions). | Providing medication at the end of the study, giving patients information, benefits for individuals and the community. |
Others (3 mentions). | Management and operation of health services [Authorities]. Intervention by specialists in philosophy of science [Justification in clinical research]. Data protection. [Ethics in a study evaluation, monitoring]. |